Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren's syndrome

R. P. E. Pollard*, W. H. Abdulahad, H. Bootsma, P. M. Meiners, F. K. L. Spijkervet, M. G. Huitema, J. G. M. Burgerhof, A. Vissink, F. G. M. Kroese

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

28 Citations (Scopus)
Original languageEnglish
Pages (from-to)2048-2050
Number of pages3
JournalAnnals of the Rheumatic Diseases
Volume72
Issue number12
DOIs
Publication statusPublished - Dec-2013

Keywords

  • B cells
  • Sjogren's Syndrome
  • Cytokines
  • Treatment
  • Chemokines
  • RITUXIMAB TREATMENT
  • AUTOIMMUNE-DISEASE
  • TRIAL

Cite this